Medtronic PLC (MDT)

85.58
0.88 1.04
NYSE : Health Care
Prev Close 84.70
Open 85.14
Day Low/High 83.86 / 86.00
52 Wk Low/High 69.35 / 89.27
Volume 7.19M
Avg Volume 4.14M
Exchange NYSE
Shares Outstanding 1.37B
Market Cap 115.82B
EPS 2.50
P/E Ratio 29.90
Div & Yield 1.72 (2.00%)

Latest News

Week Ahead: With Trump Out of Washington, the Focus Returns to Fed Forecasts

Week Ahead: With Trump Out of Washington, the Focus Returns to Fed Forecasts

Prepare for a week of Fedspeak as members prime markets for a potential interest rate hike in June.

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Ahead of Fed's June meeting, investors will need to start paying close attention to Fed officials and economic data.

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)

First serious down day in ages? Jim Cramer says it's as normal as rain; and he has an umbrella for you.

Medtronic Stock Falls Following 'Neutral' Goldman Sachs Initiation

Medtronic Stock Falls Following 'Neutral' Goldman Sachs Initiation

The firm gave the company an $87 price target.

3 Health Care Stocks to Own for 2017

3 Health Care Stocks to Own for 2017

Medtronic, J&J and Cardinal Health appear poised to benefit from an aging U.S. population, say investment experts.

Cramer: These Sectors Look Bullish (Part III)

Cramer: These Sectors Look Bullish (Part III)

From Abbott Labs to Wynn, these names rate checking out.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

The Market Is Ready to Change the Pattern

Consider how paltry the number of stocks making new highs has been.

Hit by Generic Deflation, Cardinal Health Expects Pricing to Stabilize Through 2017

Hit by Generic Deflation, Cardinal Health Expects Pricing to Stabilize Through 2017

The Cordis and Medtronic acquisitions are meant to shield Cardinal from the pricing swings of drug distribution.

Cardinal Reports A Healthy Third Quarter

Cardinal Reports A Healthy Third Quarter

Cardinal Health had reported that it expects full year adjusted earnings on the lower end of its guidance.

Good Medicine Makes for 3 Good Charts

Good Medicine Makes for 3 Good Charts

Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.

It's the Earnings, Not the Politics: Cramer's 'Mad Money' Recap (Tuesday 4/25/17)

It's the Earnings, Not the Politics: Cramer's 'Mad Money' Recap (Tuesday 4/25/17)

Jim Cramer maintains this rally is fueled by the strong performance of U.S. companies, but says it's worth assessing stock market valuations.

Mazor Robotics: Cramer's Top Takeaways

Mazor Robotics: Cramer's Top Takeaways

Ori Hadomi, CEO of Mazor Robotics, tells Jim Cramer about growth opportunities in health technology.

Turnarounds are Tenuous Things: Cramer's 'Mad Money' Recap (Wednesday 04/19/17)

Turnarounds are Tenuous Things: Cramer's 'Mad Money' Recap (Wednesday 04/19/17)

IBM's busted turnaround and difficult transition story shaved more than 50 points off the Dow, says Jim Cramer.

Cardinal Health Stock Tanks on Guidance Cut, Buys Medtronic Medical Supplies Units

Cardinal Health Stock Tanks on Guidance Cut, Buys Medtronic Medical Supplies Units

Cardinal bought Medtronic's medical supplies businesses for $6.1 billion.

Cramer: These Stocks Look Like 'Easy Pickings'

Cramer: These Stocks Look Like 'Easy Pickings'

From Aetna to United Technologies, these names are hot.

Cramer: The Best Performers Show No Signs of Letting Up

Cramer: The Best Performers Show No Signs of Letting Up

Their overseas business has been carrying them.

Stocks Give Back Gains as Trump, Xi Prepare to Kick Off Two-Day Summit

Stocks Give Back Gains as Trump, Xi Prepare to Kick Off Two-Day Summit

Stocks give back gains on Thursday afternoon as Donald Trump prepares to meet with China's President Xi Jinping for a two-day summit.

Stocks Rise Modestly Ahead of Trump-Xi Meeting, U.S. Jobs Report

Stocks Rise Modestly Ahead of Trump-Xi Meeting, U.S. Jobs Report

Stocks creep cautiously higher ahead of the U.S. jobs report for March on Friday and a possibly contentious meeting between Donald Trump and China's President Xi Jinping.

Stock Futures Rise but in 'Wait-and-See' Mode Ahead of Trump-Xi Meeting, U.S. Jobs Report

Stock Futures Rise but in 'Wait-and-See' Mode Ahead of Trump-Xi Meeting, U.S. Jobs Report

Stock futures are higher Thursday as investors remain cautious ahead of the U.S. jobs report on Friday and meeting between Donald Trump and China's Xi Jinping.

Medtronic Stock Gaining on Reported Deal to Sell Medical Supplies Unit

Medtronic Stock Gaining on Reported Deal to Sell Medical Supplies Unit

Medtronic is said to be close to a $6 billion deal to sell its medical supplies unit.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures turn higher Thursday after the Fed commits to further monetary tightening in 2017. Investors also are anticipating the meeting between Donald Trump and Chinese leader Xi Jinping.

Intel Elects Two New Members to Its Board

Intel Elects Two New Members to Its Board

Intel added executives from Medtronic and Boeing to its board of directors.

What's Behind IBM's Big Artificial Intelligence Deal With Salesforce

What's Behind IBM's Big Artificial Intelligence Deal With Salesforce

The tie-up between Big Blue and the cloud CRM software leader highlights IBM's unique AI position and strengths.

IBM's Deal With Salesforce Highlights the Company's Unique AI Position

IBM's Deal With Salesforce Highlights the Company's Unique AI Position

When it comes to AI solutions meant for specific industries, IBM has a lot of expertise and the ability to cast a broad net.

Masimo's Stock Is a Great Buy Right Now

Masimo's Stock Is a Great Buy Right Now

This patient-monitoring device-maker has plenty of room for growth.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.